The protective effect of Schisandra chinensis (Turcz.) Baill. polysaccharide on DSS-induced ulcerative colitis in mice via the modulation of gut microbiota and inhibition of NF-κB activation.
NF-κB pathway
Schisandra chinensis (Turcz.) Baill polysaccharide
gut microbiota
oxidative stress
ulcerative colitis
Journal
Journal of the science of food and agriculture
ISSN: 1097-0010
Titre abrégé: J Sci Food Agric
Pays: England
ID NLM: 0376334
Informations de publication
Date de publication:
15 Jan 2024
15 Jan 2024
Historique:
revised:
24
07
2023
received:
06
04
2023
accepted:
03
08
2023
pubmed:
9
8
2023
medline:
9
8
2023
entrez:
9
8
2023
Statut:
ppublish
Résumé
Schisandra chinensis (Turcz.) Baill, a fruit utilized in traditional Chinese medicine (TCM), has a long history of medical application. It has been used to treat diseases of the gastrointestinal tract. Schisandra chinensis (Turcz.) Baill polysaccharide (SACP) is an important biologically active ingredient that has been shown to have a variety of beneficial effects including immune regulation and anti-oxidative properties. Ulcerative colitis (UC) is a complicated gastrointestinal inflammatory disease. We explore the protective effect of SACP against UC. Schisandra chinensis (Turcz.) Baill polysaccharide significantly reduced the disease activity index (DAI) and levels of myeloperoxidase(MPO) and malondialdehyde (MDA) in colonic tissue. It also alleviated weight loss and histopathological damage of mice. The expression of MUC2 and occludin proteins was increased and the barrier function of the colonic mucosa was enhanced by SACP treatment. NF-κB pathway activation was also inhibited and the production of pro-inflammatory cytokines was decreased whereas anti-inflammatory cytokines were increased. 16SrDNA sequencing of fecal flora showed that SACP increased the abundance of Muribaculaceaeunclassified, LachnospiraceaeNK4A136group and reduced the abundance of Bacteroides and Erysipelatoclostridium. Schisandra chinensis (Turcz.) Baill polysaccharide can protect against Dextran Sulfate Sodium Salt (DSS)-induced ulcerative colitis in mice. © 2023 Society of Chemical Industry.
Sections du résumé
BACKGROUND
BACKGROUND
Schisandra chinensis (Turcz.) Baill, a fruit utilized in traditional Chinese medicine (TCM), has a long history of medical application. It has been used to treat diseases of the gastrointestinal tract. Schisandra chinensis (Turcz.) Baill polysaccharide (SACP) is an important biologically active ingredient that has been shown to have a variety of beneficial effects including immune regulation and anti-oxidative properties. Ulcerative colitis (UC) is a complicated gastrointestinal inflammatory disease. We explore the protective effect of SACP against UC.
RESULTS
RESULTS
Schisandra chinensis (Turcz.) Baill polysaccharide significantly reduced the disease activity index (DAI) and levels of myeloperoxidase(MPO) and malondialdehyde (MDA) in colonic tissue. It also alleviated weight loss and histopathological damage of mice. The expression of MUC2 and occludin proteins was increased and the barrier function of the colonic mucosa was enhanced by SACP treatment. NF-κB pathway activation was also inhibited and the production of pro-inflammatory cytokines was decreased whereas anti-inflammatory cytokines were increased. 16SrDNA sequencing of fecal flora showed that SACP increased the abundance of Muribaculaceaeunclassified, LachnospiraceaeNK4A136group and reduced the abundance of Bacteroides and Erysipelatoclostridium.
CONCLUSION
CONCLUSIONS
Schisandra chinensis (Turcz.) Baill polysaccharide can protect against Dextran Sulfate Sodium Salt (DSS)-induced ulcerative colitis in mice. © 2023 Society of Chemical Industry.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
196-206Informations de copyright
© 2023 Society of Chemical Industry.
Références
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769-2778 (2017).
Segal JP, LeBlanc JF and Hart AL, Ulcerativecolitis: anupdate. Clin Med 21:135-139 (2021).
Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L and Colombel JF, Ulcerativecolitis. Lancet 389:1756-1770 (2017).
Tian T, Wang Z and Zhang J, Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid Med Cell Longev 4535194:1-18 (2017).
Shastri S, Shinde T, Sohal SS, Gueven N and Eri R, Idebenone protects against acute murine colitis via antioxidant and anti-inflammatory mechanisms. Int J Mol Sci 21:484 (2020).
Guo XY, Liu XJ and Hao JY, Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J Digesetive Dis 21:147-159 (2020).
Kayama H, Okumura R and Takeda K, Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu Rev Immunol 38:23-48 (2020).
Glick LR, Cifu AS and Feld L, Ulcerative colitis in adults. JAMA 324:1205-1206 (2020).
Nowak A, Zakłos-Szyda M, Błasiak J, Nowak A, Zhang Z and Zhang BL, Potential of Schisandra chinensis (Turcz.) Baill. in human health and nutrition: a review of current knowledge and therapeutic perspectives. Nutrients 11:333 (2019).
Chen XY, Tang R, Liu TT, Dai W et al., Physicochemical properties, antioxidant activity and immunological effects in vitro of polysaccharides from Schisandra sphenanthera and Schisandra chinensis. Int J Biol Macromol 131:744-751 (2019).
Fang YK et al., Polysaccharides extracted from rhizoma pleionis have antitumor properties in vitro and in an H22 mouse hepatoma ascites model in vivo. Int J Mol Sci 19:1386 (2018).
Xu ZX, Chen WC, Deng QC, Huang QD, Wang X, Yang C et al., Flaxseed oligosaccharides alleviate DSS-induced colitis through modulation of gut microbiota and repair of intestinal barrier in mice. Food Funct 11:8077-8088 (2020).
Ma JM, Yin GH, Lu ZB, Xie P, Zhou HL, Liu JS et al., Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF-κB pathway and ROS signaling. Phytother Res 32:1770-1783 (2018).
Neurath MF, Host-microbiota interactions in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17:76-77 (2020).
Popov J, Caputi V, Nandeesha N, Rodriguez DA and Pai N, Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. Int J Mol Sci 22:11365 (2021).
Kopustinskiene DM and Bernatoniene J, Antioxidant effects of schisandra chinensis fruits and their active constituents. Antioxidants 10:620 (2021).
Zong S, Ye ZY, Zhang XM, Chen H and Ye M, Protective effect of Lachnum polysaccharide on dextran sulfate sodium-induced colitis in mice. Food Funct 11:846-859 (2020).
Eichele DD and Kharbanda KK, Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol 23:6016-6029 (2017).
Bhattacharyya A, Chattopadhyay R, Mitra S and Crowe SE, Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94:329-354 (2014).
Jeon YD, Lee JH, Lee YM and Kim DK, Puerarin inhibits inflammation and oxidative stress in dextran sulfate sodium-induced colitis mice model. Biomed Pharmacother 124:109847 (2020).
Lu PD and Zhao YH, Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med 15:15 (2020).
Zhang ZC, Shen P, Xie WB, Cao HY, Liu JX, Cao YG et al., Pingwei San ameliorates dextran sulfate sodium-induced chronic colitis in mice. J Ethnopharmacol 236:91-99 (2019).
Li RY, Chen YY, Shi MJ, Xu XX, Zhao YX, Wu XJ et al., Gegen qinlian decoction alleviates experimental colitis via suppressing TLR4/NF- κB signaling and enhancing antioxidant effect. Phytomedicine 23:1012-1020 (2016).
Burgueño JF and Abreu MT, Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol 17:263-278 (2020).
Dejban P, Nikravangolsefid N, Chamanara M, Dehpour A and Rashidian A, The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4/NF-kappa B pathway. Phytother Res 35:835-845 (2021).
Wang Y, Xie Q, Zhang Y, Ma W, Ning K, Xiang JY et al., Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10,and barrier function. Appl Microbiol Biotechnol 104:335-349 (2020).
Amirshahrokhi K, Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice. Int Immunopharmacol 76:105884 (2019).
Pickard JM, Zeng MY, Caruso R and Núñez G, Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 279:70-89 (2017).
Nishida A, Inoue R, Inatomi O, Bamba SG, Naito YJ and Andoh A, Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol 11:1-10 (2018).
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M and Nageshwar RD, Role of the normal gut microbiota. World J Gastroenterol 21:8787-8803 (2015).
Shin N-R, Whon TW and Bae J-W, Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends. Biotechnology 33:496-503 (2015).
Lagkouvardos I, Lesker TR, Hitch TCA, Gálvez EJC, Smit N, Neuhaus K et al., Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. Microbiome 7:28 (2019).
Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL et al., Commensal bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9:390-403 (2011).
Li AL, Ni WW, Zhang QM, Li Y, Zhang X, Wu HY et al., Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate-induced colitis. Microbiol Immunol 64:23-32 (2020).